Recombinant human serum albumin/interferon alpha2b fusion protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human serum albumin/interferon alpha2b fusion protein, covering 2021-04-01 to 2021-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient [Phase 1, Phase 2]